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The operation of portacaval anastomosis was followed by impaired oral fructose tolerance, but did not significantly change oral glucose tolerance. Plasma insulin levels were unchanged by the operation, either fasting orfollowing the stimulus of an oral glucose load or intravenous tolbutamide.
The insulin response after operation was only higher after intensive pancreatic P cell stimulation by a combination of glucose, tolbutamide, and glucagon. These results indicate that, in patients with hepatic dysfunction, little insulin is being removed by the liver from the portal blood except when the insulin secretory rate is unusually high.
Normally all carbohydrate from the intestine and insulin from the pancreas passes through the liver before reaching the systemic circulation. After the operation of portacaval anastomosis ( Fig. 1 ) changes in carbohydrate metabolism might be expected because the liver has been bypassed. No systematic studies have been undertaken to investigate this possibility and the few clinical reports provide contradictory evidence. Thus the occasional development of diabetes mellitus has been noted whereas in other patients preexisting diabetes has been found to improve after the operation (Hearn and Paton, 1963) . Another study of interest in this context is that of Megyesi, Samols, and Marks (1967) who performed oral glucose tolerance tests on four patients with portacaval anastomoses. They obtained similar blood sugar responses to those found in patients with untreated cirrhosis, but the rise of plasma insulin was unusually high. They pointed out that the latter finding was consistent with the claim that 20-50% of the insulin secreted by the pancreas is removed during its initial transhepatic passage (Samols and Ryder, 1961) , thus reducing the amount of insulin reaching the systemic circulation.
The effect ofportacaval anastomosis on oral cardohydrate tolerance and on plasma insulin levels In the present investigation patients have been studied both before and after portacaval anastomoses, using glucose, fructose, tolbutamide, and a combination of glucagon, tolbutamide, and glucose.
Patients and Methods
A total of 11 patients were investigated all of whom had portal hypertension. They had previously bled at least once from oesophageal varices and were shown at operation to have a patent portal vein. Each patient was studied before and again three to four weeks after an end-to-side portacaval anastomosis had been performed. The tests were carried out at a time when they were ambulant and taking a diet liberal in carbohydrate. All blood samples were taken using an indwelling cannula inserted in a forearm vein.
One group of six patients was studied by means of oral fructose and glucose tolerance tests. Three of these patients had cirrhosis, the aetiology being alcoholic in two and cryptogenic in the third; they had impaired hepatic cellular function causing episodes of precoma. Three patients had less evidence of hepatocellular damage. Two of these were jaundiced, the diagnosis being cryptogenic macronodular cirrhosis with cholestatic features, and the third patient had non-cirrhotic intrahepatic portal hypertension (Zeegen, Stansfeld, Dawson, and Hunt, 1970) . The tolerance tests were performed in the conventional manner, with blood samples being taken fasting and subsequently at regular intervals following the ingestion of fructose or glucose.
The second group comprised five patients with cirrhosis of whom three were alcoholic and two cryptogenicinorigin. Blood glucose and insulin levels were determined before and at intervals after the intravenous administration of lg of tolbutamide and, on separate occasions, during a 'maximum' stimulation test (Ryan, Nibbe, and Schwartz, 1967) . This involved the oral administration of 50 g of glucose-followed after 30 minutes by the intravenous injection, over the course of one minute, of 0 5 g of tolbutamide and 1 mg of glucagon.
Glucose levels were determined by a specific glucose oxidase technique (Huggett and Nixon, 1957) and fructose by a colorimetric procedure (Zender and Falbriard, 1966) . Plasma levels of immunoreactive insulin were determined by radioimmunoassay, employing dextran-coated charcoal to separate the bound and free fractions (Herbert, Lau, Gottlieb, and Bleicher, 1965) . The significance of changes in blood glucose and plasma insulin was assessed by means of a paired t test.
Results

FRUCTOSE TOLERANCE TESTS
In the three patients with relatively good preoperative liver function mean blood fructose levels were higher throughout the tests after operation ( was 30.0 mg/100 ml, which is significantly greater than that before operation, which was 15.7 mg/100 ml (p < 0.05). In the other three patients fructose tolerance did not change after operation (Figure 2b ). This can be attributed to their clearly abnormal fructose tolerance before surgery, and is consistent with the fact that they had poorer liver function by other criteria. We have found comparable abnormalities of fructose tolerance in many patients with severely impaired hepatic function due either to cirrhosis or to viral hepatitis (unpublished observations).
ORAL GLUCOSE TOLERANCE TESTS
In the same six patients, after oral glucose, neither the individual nor the mean glucose and insulin levels were affected by portacaval anastomosis (Figure 3 ). The rise in plasma insulin (dl), compared with the rise in blood glucose (dG), expressed as a ratio dI/dG (Seltzer, Allen, Herron, and Brennan, 1967) for nine patients (including three patients who had a glucose, glucagon, tolbutamide test) at 15 and 30 minutes after oral glucose was not significantly different after operation. At 15 minutes the ratio was 2.0 ± 0.66 (M ± SE) before, and 1.71 + 0.63 after, operation, and at 30 minutes 2-0 + 0.56 before, and 2.1 + 0.54 after, operation.
INTRAVENOUS TOLBUTAMIDE TESTS
The results of intravenous tolbutamide tests before and after surgery in the second group of five patients are shown in Figure 4 . There was no significant difference in either the fall of blood sugar or rise of insulin. Although there was a tendency for plasma cult to reconcile with previous claims that the liver ry high levels removes much secreted insulin before it reaches the in peak being systemic circulation (Samols and Ryder, 1961 group.bmj.com on June 25, 2017 -Published by http://gut.bmj.com/ Downloaded from liver from observations on patients with liver disease, it may be noted that similar results were obtained in three patients with relatively good liver function. In these patients diversion of portal blood resulted in impaired fructose metabolismbut therewas no significant change in plasma insulin levels following oral glucose or intravenous tolbutamide. However, the more marked increase in plasma insulin levels following oral glucose, glucagon, and tolbutamide after operation suggests that the liver may remove secreted insulin from the blood when portal vein insulin levels are very high. This conclusion has also been reached as a result of experiments in dogs (Waddell and Sussman, 1967) .
An additional factor which could affect insulin response after diversion of portal blood is the glncagon-like hormone released by the mucosa of the small intestine after oral glucose (McIntyre, Holdsworth, and Turner, 1965) (Fig. 1 ) which stimulates insulin release, since this substance may also be removed by the liver (Buchanan, Solomon, Vance, Porter, and Williams, 1968) . Our results suggest that hepatic removal of intestinal factors which stimulate insulin secretion is likely to be of only minor importance.
The fall in blood glucose following intravenous tolbutamide was very similar after operation to that seen before operation. This suggests that the hypoglycaemic effect of insulin is the same, whether it passes through the liver first or is secreted directly into the systemic circulation. Similar conclusions have been reached from dog experiments, which showed a similar hypoglycaemic response, following intraportal or systemic injection of insulin (Madison and Unger, 1958; Starzl, Scanlan, Yanof, Thornton, Wendel, Stearn, Lazarus, McAllister, and Shoemaker, 1963) .
In patients with cirrhosis of the liver the abnormal pattern of carbohydrate metabolism has been compared with that of maturity onset diabetes and obesity, as impaired glucose tolerance and endogenous and exogenous insulin resistance are found in both conditions (Megyesi, Samols, and Marks, 1967; Samols and Holdsworth, 1968) but the normal insulin increment dI/dG in our patients is unlike diabetes (Seltzer et al, 1967) , and suggests obesity as the closer analogue. The high plasma insulin levels found both fasting and after oral glucose have been attributed in part to portal systemic shunting of blood and in part to an increased islet cell response, due to endogenous insulin resistance (Megyesi et al, 1967 ). Our observations suggest that the increased islet cell response is the more important factor. In contrast to Samols and Turner (1968) , who did not study the same patients before and after portacaval shunts, we did not find a higher plasma insulin response to tolbutamide after operation, but we agree with these authors that patients with hepatic cirrhosis show a supranormal rise in plasma insulin after intravenous tolbutamide. The islet cells of patients with hepatic cirrhosis, again rather as in obesity (Perley and Kipnis, 1967) , appear to hyperreact to a variety of insulinogenic stimuli and the degree of response in any one patient is roughly the sameforeach type of stimulus (Table I) 
